A semi-parametric approach to fitting a nonlinear mixed PK/PD model with an effect compartment using SAS.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 59, doi. 10.1002/pst.154
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2005 AND VI 4 AND IP 1
Results: 13
1
2
Evaluation of a weighted multiple comparison procedure.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 7, doi. 10.1002/pst.136
- By:
- Publication type:
- Article
3
Nonlinear mixed effects modelling for estimation of steady state attainment.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 15, doi. 10.1002/pst.147
- By:
- Publication type:
- Article
4
Textbook of clinical trials Machin D, Day S, Green S (editors) (2004) ISBN 0471987875; 428 pages; £150; €225; $278 Wiley;.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 82, doi. 10.1002/pst.158
- By:
- Publication type:
- Article
5
Rejoinder.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 73, doi. 10.1002/pst.160
- Publication type:
- Article
6
Modelling and simulation to improve decision-making in clinical development.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 47, doi. 10.1002/pst.153
- By:
- Publication type:
- Article
7
Decision making in health and medicine Hunink M, Glasziou P, Siegel J, Weeks J, Pliskin J, Elstein A, Weinstein MC (2001) ISBN 0521770297; 404 pages; £38; $60 Cambridge University Press;.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 81, doi. 10.1002/pst.157
- By:
- Publication type:
- Article
8
Comment on 'morbidity measures in the presence of recurrent composite endpoints', Scott M, Möcks J, Givens S, et al. Pharmaceutical Statistics 2003; 2(1):39-49.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 71, doi. 10.1002/pst.152
- By:
- Publication type:
- Article
9
Editorial.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 1, doi. 10.1002/pst.163
- By:
- Publication type:
- Article
10
Moving statistics beyond the individual clinical trial: applying decision science to optimize a clinical development plan.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 37, doi. 10.1002/pst.149
- By:
- Publication type:
- Article
11
Why do we use pooled variance analysis of variance?
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 3, doi. 10.1002/pst.155
- By:
- Publication type:
- Article
12
Performance of some multiple testing procedures to compare three doses of a test drug and placebo.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 25, doi. 10.1002/pst.148
- By:
- Publication type:
- Article
13
Literature review September-December 2004.
- Published in:
- Pharmaceutical Statistics, 2005, v. 4, n. 1, p. 77, doi. 10.1002/pst.159
- By:
- Publication type:
- Article